Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists.

Trends in pharmacological sciences

Volumn 18, Issue 9, 1997, Pages 307-310

  Williams, M ^a   Wright, S ^a   Lloyd, G K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DRD3 PROTEIN, HUMAN; DRD3 PROTEIN, RAT;

ANIMAL; DRUG POTENTIATION; HUMAN; NOTE; PARKINSON DISEASE; RAT;

ANIMALS; ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; HUMANS; PARKINSON DISEASE; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0031225736     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0165-6147(97)90650-7     Document Type: Note

References (0)